Latest Treatment for depression Stories

2009-04-30 15:46:49

U.S. scientists say they have identified an acid-sensitive brain protein that might become a new drug target for the treatment of depression Investigators at the University of Iowa led by researcher Matthew Coryell and Dr.

2009-04-29 08:30:53

Findings from clinical studies used to gain Food and Drug Administration approval of common antidepressants are not applicable to most patients with depression, according to a report led by the University of Pittsburgh Graduate School of Public Health.

2009-04-21 09:08:00

Novel device for the treatment of depression named one of 2008's top medical device innovations MALVERN, Pa., April 21 /PRNewswire/ --- NeuroStar(R) TMS (Transcranial Magnetic Stimulation) Therapy system, the first and only non-systemic and non-invasive treatment cleared by the FDA for Major Depressive Disorder, is a recipient of the prestigious Medical Design Excellence Award (MDEA).

2009-04-07 06:58:00

BRIDGEWATER, N.J., April 7 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S.

2009-03-20 12:38:00

NEW YORK, March 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S.

2009-02-09 09:26:42

Much has been written about the link between drugs used to treat depression and the risk of suicide.

2009-01-15 15:22:07

In a national clinical trial, adolescents with moderate to severe depression first given a placebo treatment and then an antidepressant medication alone or in combination with therapy responded just as well over the long term as participants who received active treatment throughout the study, UT Southwestern Medical Center researchers report.

2009-01-05 07:10:00

ANN ARBOR, Mich., Jan. 5 /PRNewswire-USNewswire/ -- When Lamont Christian returned from war, he often felt angry, afraid and unworthy.

2008-12-22 07:00:00

NEW YORK and PARIS, Dec. 22, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Pierre Fabre Medicament today announced that they have entered into a definitive collaboration agreement to develop and commercialize F2695 in the United States and Canada.

2008-11-06 09:00:12

MALVERN, Pa., Nov. 6 /PRNewswire/ -- Neuronetics, Inc. announced today that a new health economic study evaluating the cost effectiveness of its NeuroStar TMS Therapy system in the treatment of depression was presented at the U.S. Psychiatric and Mental Health Congress in San Diego last week.

Word of the Day
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.